2m 2m 2m 2m 2m 2m 2m
Lexicon Pharma (LXRX)
NASDAQ
$2.28-$0.02 (-0.87%)
Price as of Aug 21, 2026 7:30 PM EDT- $1.0BMarket Cap
- 93.28%1-Year Change
- BiotechnologyIndustry
Lexicon Pharma (LXRX)
$2.28-$0.02 (-0.87%)
LXRX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.30 | ||
Change | +$0.12 (+5.50%) | ||
Open | $2.19 | ||
High | $2.31 | ||
Low | $2.19 | ||
Previous Close | $2.18 | ||
Volume | 3,194,806 | ||
30-Day Average Volume | 2,946,954 | ||
1-Week Change | -0.86% | ||
1-Month Change | -3.36% | ||
1-Year Change | 93.28% | ||
3-Year Change | 32.18% | ||
5-Year Change | -33.72% | ||
Fundamentals | |||
Shares Outstanding | 445.0M | ||
Total Assets | $250.1M | ||
Market Cap | $1.0B | ||
Enterprise Value | $1.0B | ||
Period: QTR TTM FY | |||
Revenue | $692,000.00 | ||
Net Income | -$31.8M | ||
Free Cash Flow | -$9.2M | ||
EBIT | -$31.8M | ||
EBITDA | -$31.7M | ||
Net Working Capital | $181.9M | ||
EPS | -$0.07 | ||
Enterprise Value/EBITDA | -33 | ||
Enterprise Value/Revenue | 1,494 | ||
P/B | 6 | ||
P/E | -33 | ||
PEG | N/A | ||
Price/Free Cash Flow | -111 | ||
Price/Operating Cash Flow | -111 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 7 | ||
Last Split Date | 05/21/2015 | ||
Earnings & Revenue